KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) EBT: 2016-2024

Historic EBT for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to -$3.6 billion.

  • Moderna's EBT fell 990.48% to -$187.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 billion, marking a year-over-year decrease of 34.00%. This contributed to the annual value of -$3.6 billion for FY2024, which is 8.50% up from last year.
  • Moderna's EBT amounted to -$3.6 billion in FY2024, which was up 8.50% from -$3.9 billion recorded in FY2023.
  • In the past 5 years, Moderna's EBT ranged from a high of $13.3 billion in FY2021 and a low of -$3.9 billion during FY2023.
  • For the 3-year period, Moderna's EBT averaged around $675.3 million, with its median value being -$3.6 billion (2024).
  • In the last 5 years, Moderna's EBT skyrocketed by 1,885.62% in 2021 and then slumped by 141.17% in 2023.
  • Moderna's EBT (Yearly) stood at -$744.0 million in 2020, then surged by 1,885.62% to $13.3 billion in 2021, then dropped by 27.93% to $9.6 billion in 2022, then tumbled by 141.17% to -$3.9 billion in 2023, then grew by 8.50% to -$3.6 billion in 2024.